Showing results (1911-1920 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|August 5, 2014
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failureI Breitkreutz, C Heiss, A Perne, et al.
Bone Marrow Transplantation|December 3, 2013
Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinibN Jaekel, G Behre, A Behning, et al.
Bone Marrow Transplantation|September 3, 2013
Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measuresC W Bassim, H Fassil, J W Mays, et al.
Bone Marrow Transplantation|August 12, 2014
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCTS Fuji, K Takano, T Mori, et al.
Bone Marrow Transplantation|August 12, 2014
Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantationM Tavadze, L Rybicki, S Mossad, et al.
Bone Marrow Transplantation|December 10, 2013
Targeted Busulfan therapy with a steady-state concentration of 600-700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplantS Maheshwari, A Kassim, R F Yeh, et al.
Bone Marrow Transplantation|December 10, 2013
A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD)N Gossai, M R Verneris, N A Karras, et al.
Bone Marrow Transplantation|May 14, 2013
Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonographyE Benedetti, B Bruno, G B McDonald, et al.
Bone Marrow Transplantation|April 23, 2013
Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine modelC D Fitzhugh, R P Weitzel, M M Hsieh, et al.
Bone Marrow Transplantation|April 2, 2013
Clinical effect of individualized parenteral nutrition vs conventional method in patients undergoing autologous hematopoietic SCTM Tavakoli-Ardakani, B Neman, M Mehdizadeh, et al.
Pageof 993